A New Era for Rare Disease Diagnosis

Genorare leverages LLMpredictive analytics, and Fully Homomorphic Encryption to deliver fast, secure, and accurate insights while protecting patient privacy. With privacy at its core, Genorare ensures full GDPR and HIPAA compliance, allowing seamless adoption in hospitals, research institutions, and pharmaceutical companies.

Our mission is simple: shorten the diagnostic journey and give patients the answers they deserve—faster and more securely. Because at Genorare, every patient counts.

The rare disease diagnostic journey

Note: Descriptive phrase that serves as title and description. Adapted from EURORDIS.

It’s a waiting game, but you tell a mum to wait when she’s waited 15 years. It’s difficult.
Nuria
A diagnosis may be bad news, it may be very bad news or it may be no news. But all of that’s OK and there’s help and support for whatever spectrum you end up on.
Peter
We went around, travelling across the entire city to find a nursery for our son. It was impossible to have him accepted.
Gaston
People began to ask which side of the family it came from...It was a difficult time for us as parents.
Alexa
7 Years, $1 Trillion Wasted—Current Rare Disease Diagnosis Isn’t Working. Genorare integrates AI, privacy-preserving encryption, and real-time EHR connectivity into a single, seamless solution.
Our Focus

At Genorare, we are dedicated to transforming the way rare diseases are diagnosed by leveraging predictive intelligence, genomic data, and privacy-first technology. Our platform seamlessly integrates machine learning, Fully Homomorphic Encryption (FHE), and real-time Electronic Health Record (EHR) analysis to provide faster, more accurate, and secure diagnoses for patients worldwide.

By prioritizing speed, accuracy, and security, Genorare is redefining the future of rare disease diagnostics—because at Genorare, every patient counts.

Our Solutions

Real-Time Diagnosis Support

Our advanced predictive intelligence analyzes genomic & EHR data to assist doctors in identifying rare diseases earlier.

Privacy-First AI – Using FHE & blockchain, Genorare analyzes encrypted data without ever exposing raw patient information, ensuring GDPR & HIPAA compliance.

Seamless EHR & Genomics Integration

Works within existing hospital systems for automated, background analysis without disrupting workflows.

Clinical Trial Matching

Connects rare disease patients with pharma & biotech trials, accelerating orphan drug development.

Patient-Doctor Matching

Helps patients find specialized care faster, reducing the diagnostic odyssey. It also enables doctors to collaborate, solving the puzzle of rare diseases together and uncovering the right diagnosis through shared expertise.

Our Technology

Secure Data Collection & Encryption

Privacy-Preserving Computation

Personalized Insights & Decryption

Meet Our Team

Introducing our team of dedicated professionals driving innovation at Genorare.

Dr. Quy Vo-Reinhard
CEO/CTO/Founder
Dr. Kathrin Katemann
Venture Partner
Valeria Gottardo
Venture Developer
Nina Lameule
Venture Finance
Bart Geerts, MD
Advisor Digital Health/AI
Lucas Hofmans
Venture Analyst
Julie Szu-Chun Yang
Venture Operations
NLC Health Ventures
"Co-Founder"

Our Trusted Partners

FAQs
Get answers to common questions about our
technology and services.

Contact Us
Reach out to us for any inquiries or partnership.